These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28574406)

  • 1. Muscle abnormalities in osteogenesis imperfecta.
    Veilleux LN; Trejo P; Rauch F
    J Musculoskelet Neuronal Interact; 2017 Jun; 17(2):1-7. PubMed ID: 28574406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I.
    Veilleux LN; Lemay M; Pouliot-Laforte A; Cheung MS; Glorieux FH; Rauch F
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E356-62. PubMed ID: 24248189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Intrinsic Muscle Weakness on Muscle-Bone Crosstalk in Osteogenesis Imperfecta.
    Gremminger VL; Phillips CL
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional muscle-bone unit in patients with osteogenesis imperfecta type I.
    Veilleux LN; Pouliot-Laforte A; Lemay M; Cheung MS; Glorieux FH; Rauch F
    Bone; 2015 Oct; 79():52-7. PubMed ID: 26004918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of stomatognathic problems in children with osteogenesis imperfecta (osteogenesis imperfecta - oi) - preliminary study.
    Smoląg D; Kulesa-Mrowiecka M; Sułko J
    Dev Period Med; 2017; 21(2):144-153. PubMed ID: 28796986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory impairment impacts QOL in osteogenesis imperfecta independent of skeletal abnormalities.
    Yonko EA; Emanuel JS; Carter EM; Sandhaus RA; Raggio CL
    Arch Osteoporos; 2020 Oct; 15(1):153. PubMed ID: 33009598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment.
    Sato A; Ouellet J; Muneta T; Glorieux FH; Rauch F
    Bone; 2016 May; 86():53-7. PubMed ID: 26927310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.
    Paschalis EP; Gamsjaeger S; Fratzl-Zelman N; Roschger P; Masic A; Brozek W; Hassler N; Glorieux FH; Rauch F; Klaushofer K; Fratzl P
    J Bone Miner Res; 2016 May; 31(5):1050-9. PubMed ID: 26748579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diaphyseal Femur Fractures in Osteogenesis Imperfecta: Characteristics and Relationship With Bisphosphonate Treatment.
    Trejo P; Fassier F; Glorieux FH; Rauch F
    J Bone Miner Res; 2017 May; 32(5):1034-1039. PubMed ID: 28019684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle Function in Osteogenesis Imperfecta Type IV.
    Veilleux LN; Darsaklis VB; Montpetit K; Glorieux FH; Rauch F
    Calcif Tissue Int; 2017 Oct; 101(4):362-370. PubMed ID: 28474170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.
    Sinder BP; Salemi JD; Ominsky MS; Caird MS; Marini JC; Kozloff KM
    Bone; 2015 Feb; 71():115-23. PubMed ID: 25445450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired muscle parameters in adults with mild to severe types of osteogenesis imperfecta: a cross-sectional study.
    Coussens M; Lapauw B; De Wandele I; Malfait F; Pocovi NC; Pacey V; Calders P
    J Bone Miner Res; 2024 Apr; 39(3):260-270. PubMed ID: 38477793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta.
    Roschger A; Roschger P; Keplingter P; Klaushofer K; Abdullah S; Kneissel M; Rauch F
    Bone; 2014 Sep; 66():182-8. PubMed ID: 24953712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dentinogenesis imperfecta associated with osteogenesis imperfecta: report of two cases.
    Tsai CL; Lin YT; Lin YT
    Chang Gung Med J; 2003 Feb; 26(2):138-43. PubMed ID: 12718392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Osteogenesis Imperfecta Associated with Cardiovascular Abnormalities? A Systematic Review of the Literature.
    Verdonk SJE; Storoni S; Micha D; van den Aardweg JG; Versacci P; Celli L; de Vries R; Zhytnik L; Kamp O; Bugiani M; Eekhoff EMW
    Calcif Tissue Int; 2024 Mar; 114(3):210-221. PubMed ID: 38243143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteogenesis Imperfecta: Muscle-Bone Interactions when Bi-directionally Compromised.
    Phillips CL; Jeong Y
    Curr Osteoporos Rep; 2018 Aug; 16(4):478-489. PubMed ID: 29909596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hip Dysplasia in Children With Osteogenesis Imperfecta: Association With Collagen Type I C-Propeptide Mutations.
    Kishta W; Abduljabbar FH; Gdalevitch M; Rauch F; Hamdy R; Fassier F
    J Pediatr Orthop; 2017; 37(7):479-483. PubMed ID: 26371943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta.
    DiGirolamo DJ; Singhal V; Chang X; Lee SJ; Germain-Lee EL
    Bone Res; 2015; 3():14042. PubMed ID: 26161291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta.
    Vardakastani V; Saletti D; Skalli W; Marry P; Allain JM; Adam C
    Bone; 2014 Dec; 69():61-7. PubMed ID: 25238898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranial base pathology in pediatric osteogenesis imperfecta patients treated with bisphosphonates.
    Arponen H; Vuorimies I; Haukka J; Valta H; Waltimo-Sirén J; Mäkitie O
    J Neurosurg Pediatr; 2015 Mar; 15(3):313-20. PubMed ID: 25559924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.